SP-A - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

259199-63-8

AC-DMQD-CHO;
CASPASE-3 INHIBITOR IV;
CASPASE 3 INHIBITOR 1;
CASPASE-3 INHIBITOR (ALDEHYDE);
AC-ASP-MET-GLN-ASP-ALDEHYDE;
AC-ASP-MET-GLN-ASP-ALDEHYDE (PSEUDO ACID);
AC-ASP-MET-GLN-ASP-CHO;
AC-ASP-MET-GLN-ASP-H (ALDEHYDE);
AC-DMQD-ALDEHYDE

详情

供应商

77739-16-3

Delta sleep-inducingpeptide (rabbit), 1-D-tryptophan- (9CI);
D-Trp-Ala-Gly-Gly-ASP-Ala-Ser-Gly-Glu;
[D-Trp1]-DSIP

L-a-Asparagine,N-acetyl-L-leucyl-L-valyl-L-cysteinyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-(9CI);
AC-LEU-VAL-CYS-ASP-AMC

L-Lysine, L-a-aspartyl-L-alanyl-L-histidyl-;
L-Lysine,N2-[N-(N-L-a-aspartyl-L-alanyl)-L-histidyl]-;
11: PN: WO02064620 PAGE: 41 claimed protein;
15: PN: US20080199882 SEQID: 16unclaimed protein;
1: PN: WO0020454 SEQID: 1 claimed protein;
1: PN: WO03007686SEQID: 1 unclaimed sequence;
2: PN: US20030060408 SEQID: 1 claimed protein;
35:PN: WO03010186 SEQID: 35 claimed protein;
4: PN: WO2004054431 PAGE: 13 unclaimedsequence;
ASP-Ala-His-Lys;
DMI 4983

AC-LEHD-AFC;
N-ACETYL-LEU-GLU-HIS-ASP 7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;
N-ACETYL-LEU-GLU-HIS-ASP-(7-AMINO-4-TRIFLUOROMETHYLCOUMARIN);
N-ACETYL-LEU-GLU-HIS-ASP-7-AMINO-4-TRIFLUOROMETHYLCOUMARIN AFC;
AC-LEU-GLU-HIS-ASP-7-AMINO-4-TRIFLUORO-METHYLCOUMARIN;
AC-LEU-GLU-HIS-ASP-AFC;
AC-LEHD-AFC;
CASPASE-9 SUBSTRATE I, FLUOROGENIC;
CASPASE 9 SUBSTRATE 1F, FLUOROGENIC

AC-YVAD-AFC;
N-ACETYL-TYR-VAL-ALA-ASP 7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;
CASPASE-1 SUBSTRATE XII, FLUOROGENIC;
CASPASE 1 (ICE) SUBSTRATE 2F, FLUOROGENIC;
AC-YVAD-AFC;
AC-TYR-VAL-ALA-ASP-7-AMINO-4-TRIFLUOROMETHYL COUMARIN;
AC-TYR-VAL-ALA-ASP-AFC;
N-Acetyl-Tyr-Val-Ala-Asp-(7-amino-4-trifluoromethylcoumarin);
M.W. 719.67 C33H36F3N5O10

SP-ADENOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE TRIETHYLAMINE;
adenosine-3’,5’-cyclicmonophosphorothioate,sp-isomer(sp-camps),triethylammonium;
ADENOSINE 3',5'-CYCLIC PHOSPHOROTHIOATE-SP, TRIETHYLAMMONIUM SALT;
ADENOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE, SP-ISOMER TRIETHYLAMMONIUM SALT;
ADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, SP-ISOMER TRIETHYL AMMONIUM SALT;
CAMPS-SP, TRIETHYLAMMONIUM SALT;
CAMPS TEA, SP-ISOMER;
SP-CYCLIC 3',5'-HYDROGEN PHOSPHOROTHIOATE ADENOSINE TRIETHYLAMINE;
SP-CAMPS TEA

ADENOSINE-5'-O-(1-THIODIPHOSPHATE), RP-ISOMER SODIUM SALT;
SP-ADP-ALPHA-S SODIUM SALT;
RP-ADP-ALPHA-S SODIUM SALT;
adenosine-5’-o-(1-thiodiphosphate),spisomer(SP-Adp-@-s),sodiumsalt;
ADENOSINE-5'-O-(1-THIODIPHOSPHATE), RP-ISOMER SODIUM SALT;
ADENOSINE-5'-O-(1-THIODIPHOSPHATE), SP-ISOMER SODIUM SALT;
Adenosine-5''-O-(1-thiodiphosphoric acid), Sp-isomer

(ALA92)-PEPTIDE 6

(ALA92)-P16 (84-103);
OSTEOCALCIN [ALA92]-P16 FRAGMENT 84-103;
OSTEOCALCIN [ALA92]-PEPTIDE 6;
H-ASP-ALA-ALA-ARG-GLU-GLY-PHE-LEU-ALA-THR-LEU-VAL-VAL-LEU-HIS-ARG-ALA-GLY-ALA-ARG-OH;
ASP-ALA-ALA-ARG-GLU-GLY-PHE-LEU-ALA-THR-LEU-VAL-VAL-LEU-HIS-ARG-ALA-GLY-ALA-ARG;
(ALA92)-P16 (84-103);
(ALA92)-PEPTIDE 6;
[ala92]-p16 fragment 84-103

HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-ALA-LEU-ASN-SER-

(ALA11,22,28)-VIP (HUMAN, BOVINE, PORCINE, RAT);
HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-ALA-LEU-ASN-SER-ILE-LEU-ALA-NH2;
H-HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-ALA-LEU-ASN-SER-ILE-LEU-ALA-NH2;
[ALA11,22,28]VIP;
(ALA11,22,28)-VIP (HUMAN, BOVINE, PORCINE, RAT);
[ALA11,22,28]VIP, HUMAN, PORCINE, RAT;
H-His-Ser-ASP-Ala-Val-Phe-Thr-ASP-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2;
M.W. 3160.65 C139H231N43O39S

HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-;
[ALA2,8,9,11,19,22,24,25,27,28]-VIP;
HIS-ALA-ASP-ALA-VAL-PHE-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2

ASP-ARG-LEU-TYR-SER-PHE-GLY-LEU-NH2

ALLATOSTATIN IV;
ALLATOSTATIN IV;
H-ASP-ARG-LEU-TYR-SER-PHE-GLY-LEU-NH2;
DRLYSFGL-NH2;
ASP-ARG-LEU-TYR-SER-PHE-GLY-LEU-NH2;
TYPE A ALLATOSTATIN IV;
Type A Allatostatin IV ASP-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2

H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH

H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GL;
PREDOMINANT AMYLOID B-PROTEIN FRAGMENT;
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA;
ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA;
BAP 1-42;
BETA-AMYLOID, SODIUM SALT;
BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT;
BETA-AMYLOID PEPTIDE (1-40), RAT;
BETA-AMYLOID PEPTIDE (1-42), RAT

无

血管紧张素原

ANGIOTENSINOGEN;
H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-LEU-VAL-TYR-SER-OH;
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-LEU-VAL-TYR-SER;
ANGIOTENSINOGEN FRAGMENT 1-14 PORCINE;
ANGIOTENSINOGEN (1-14), PORCINE;
ANGIOTENSINOGEN (1-14) (HORSE);
ANGIOTENSINOGEN;
PREANGIOTENSINOGEN (1-14) (HORSE);
RENIN SUBSTRATE

血管紧张素II

ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE ACETATE SALT;
ANGIOTENSIN II ACETATE SALT;
ANGIOTENSIN II HUMAN ACETATE SALT;
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE ACETATE SALT;
HYPERTENSIN II;
ANGIOTENSIN II, MASS SPEC STANDARD;
ANGIOTENSIN II, HUMAN, SYNTHETIC;
ANGIOTENSIN II ACETATE HUMAN;
ANGIOTENSIN II-FLUORESCEIN SYNTHETIC >81 %

ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY

ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY;
H-ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY-OH;
INSULIN RECEPTOR/TYROSINE KINASE SUBSTRATE;
ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY;
RRLIEDAEYAARG;
RR-SRC;
R-R-SRC-PEPTIDE;
TYROSINE KINASE PEPTIDE 3 [RRLIEDAEYAARG];
TYROSINE KINASE SUBSTRATE RR-SRC

酪氨酸激酶

H-ARG-ARG-LEU-ILE-GLU-ASP-ASN-GLU-TYR-THR-ALA-ARG-GLY-OH;
ARG-ARG-LEU-ILE-GLU-ASP-ASN-GLU-TYR-THR-ALA-ARG-GLY;
H-ARG-ARG-LEU-ILE-GLU-ASP-ASN-GLU-TYR-THR-ALA-ARG-GLY-OH;
TYROSINE KINASE SUBSTRATE;
RRLIEDNEYTARG;
PP60(V-SRC) AUTOPHOSPHORYLATION SITE;
PP60V-SRC FRAGMENT;
arg-arg-leu-ile-glu-aSP-Asn-glu-tyr-*thr-ala-arg-;
TYROSINE KINASE SUBSTRATE SYNTHETIC >96%

ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-

ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-;
H-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH;
ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28;
ATRIAL NATRIURETIC FACTOR (3-28) (RAT);
ATRIAL NATRIURETIC PEPTIDE (3-28), RAT;
A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28);
ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR;
ANP (RAT, 3-28);
ANP (3-28), RAT

AUTOCAMTIDE-2-RELATED INHIBITORY PEPTIDE

AUTOCAMTIDE-2-RELATED INHIBITORY PEPTIDE;
(ALA9)-AUTOCAMTIDE-2;
ALS9 AUTOCAMTIDE 2;
ALP;
LYS-LYS-ALA-LEU-ARG-ARG-GLN-GLU-ALA-VAL-ASP-ALA-LEU;
KKALRRQEAVDAL;
AUTOCAMTIDE 2-RELATED INHIBITORY PEPTIDE, MYRISTOYLATED TRIFLUOROACETATE SALT;
AUTOCAMTIDE-2-RELATED INHIBITORY PEPTIDE;
ESKINE

NATRIURETIC PEPTIDE, C-TYPE;
CNP

C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT);
NATRIURETIC PEPTIDE, C-TYPE, HUMAN AND PORCINE;
GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS;
GLSKGCFGLKLDRIGSMSGLGC;
GLSKGCFGLKLDRIGSMSGLGC (DISULFIDE BRIDGE: 6-22);
H-GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS-OH;
H-GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS-OH (DISULFIDE BRIDGE: 6-22);
CNP;
CNP-22, HUMAN

C93H157N27O28S3

详情

供应商

化工产品